Comparison between crude Interleukin-2 and recombinant Interleukin-2 in maintaining killing activity of cultured lymphocytes
β Scribed by Masaki Nakanishi; Norimichi Kan; Takashi Okino; Kohei Satoh; Keiichi Mise; Yasufumi Teramura; Seiji Yamasaki; Kazuhisa Ohgaki; Takayoshi Tobe
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 999 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0921-299X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A phase-I study of the recombinant, non-mutagenized interleukin 2 (rlL2, Bioleukin'") was performed in 12 melanoma patients (Pts). From 100 to 800 pg/m2 of rlL2 were administered by i.v. bolus injection, TID for 4-8 days. Side-effects included fever, malaise, low serum K + and C a + + values, electr
## T cell activation: independent induction of killing activity and interleukin 2 secretion in cytolytic hybridomas" Memory-like cytotoxic T lymphocytes (CTL) hybridomas exhibiting inducible killing activity and IL2 production were used to analyze the anamnestic response of CTL. Four activating ag